Abstract
Stem cell quiescence preserves the cell reservoir by minimizing cell division over extended periods of time. Self-renewal of quiescent stem cells (SCs) requires the reentry into the cell cycle. In this study, we show that murine hair follicle SCs induce the Foxc1 transcription factor when activated. Deleting Foxc1 in activated, but not quiescent, SCs causes failure of the cells to reestablish quiescence and allows premature activation. Deleting Foxc1 in the SC niche of gene-targeted mice leads to loss of the old hair without impairing quiescence. In self-renewing SCs, Foxc1 activates Nfatc1 and bone morphogenetic protein (BMP) signaling, two key mechanisms that govern quiescence. These findings reveal a dynamic, cell-intrinsic mechanism used by hair follicle SCs to reinforce quiescence upon self-renewal and suggest a unique ability of SCs to maintain cell identity.
Maintaining a pool of adult stem cells (SCs) is critical for tissue homeostasis and wound repair throughout an organism’s life. Self-renewal, a defining property of SCs, is achieved by either symmetrical or asymmetrical cell division, through which new generations of SCs are produced to replenish the SC pool(1, 2). Some SCs can also be kept in a quiescent state for a prolonged period of time to minimize cell turnover(3). Although it is well documented that cell extrinsic mechanisms such as those mediated by stem cell niche play important roles in governing the transition between quiescence and self-renewal, it is unclear whether there are cell-intrinsic mechanisms that respond to self-renewal and promote dividing SCs to return to quiescence. In this study, we investigated largely synchronized murine hair follicle SC (HFSC) populations during early adulthood to probe this layer of SC regulation.
HFSCs reside in an anatomically distinct compartment of the hair follicle, known as the bulge(4–6). During the adult hair cycle, HFSCs periodically go through the phases of activation and quiescence to maintain the SC population and produce new hair follicles(7). The Foxc1 transcription factor has been previously identified as one of the few genes with dynamic Histone modification patterns in the HFSCs(8) but its expression and function remained unknown. We first monitored Foxc1 expression during the adult hair cycle using a Foxc1-LacZ knock-in mouse(9) and immunofluorescence (IF) staining. We did not observe expression of Foxc1 in the interfollicular epidermis in any of the stages examined (fig. S1). At the first telogen (~P18), Foxc1 was absent from the bulge SC compartment but expressed in the infundibulum and sebaceous gland progenitors (Fig. 1A). By anagen III, Foxc1 was induced in both the basal and suprabasal bulge layers and the inner root sheath (IRS) (Fig. 1B). In mature HFs, Foxc1 was strongly expressed in the bulge layers and the IRS (Fig. 1C–G). When HFs progressed through the catagen and reached the second telogen (~P47), Foxc1 was again absent in the bulge (Fig. 1H–J). The induction of Foxc1 in both the K6+ suprabasal bulge layer (SBL), a putative niche for HFSCs(10), and the CD34+ HFSCs at the basal bulge layer in anagen but not in telogen was confirmed by IF staining (Fig. 1E and J). Furthermore, by examining old mice in which the hair cycle became asynchronized and all different hair cycle stages were observed in a single animal, we validated that the expression of Foxc1 inherently correlates with the hair cycle (fig. S1).
We then investigated Foxc1 function by conditionally deleting Foxc1 (cKO) in the skin. K14-Cre deletes Foxc1 in all skin lineages. Foxn1-Cre deletes Foxc1 in the SBL but not in the HFSCs. K15-CrePR deletes Foxc1 in the HFSCs but not in the SBL upon induction (Fig. 2A, fig. S2). All WT and cKO animals were born at the expected Mendelian ratios (fig. S3A) and developed normal skin neonatally, consistent with the lack of Foxc1 expression in embryonic skin progenitors (fig. S3B–C).
Compared to the WT HFs, which usually entered anagen at ~P70-P75, the K14-Cre cKO HFs had a significantly shortened telogen: the HFs entered anagen prematurely by the middle of the second telogen at ~P64 (as revealed by the darkened skin) and grew hair coat by P70 (Fig. 2B). We then examined HFSC activation in WT and cKO animals during the second adult telogen. At P47, we observed no signs of HF growth or HFSC division. However, loss of the old hair follicle (also known as club hair) was evident (Fig. 2C). By P60, HF growth was initiated in cKO mice as indicated by widespread BrdU incorporation in both the HFSCs and hair germs (HGs: the progenitors to fuel hair growth) (Fig. 2D and F). By P64, whereas cKO animals produced mature HFs, WT animals were still in quiescent telogen (fig. S4A). In the Foxn1-Cre cKO in which Foxc1 was deleted in the SBL but not in the HFSCs, no premature HF growth was observed although the loss of club hair was evident (Fig. 2E left panel). In contrast, in the K15-CrePR model in which Foxc1 was deleted before anagen, premature HF growth was observed without the loss of club hair at P60 (Fig. 2E middle panel and F). In the K15-CrePR model in which Foxc1 was deleted after anagen, neither premature HF growth nor the loss of club hair was observed at P60 (Fig. 2E right panel and F). By dyeing hair at P21 and observing subsequent loss of the dyed hair, we found the club hair was lost late in the second anagen (~P33 to P35) in the K14-Cre and Foxn1-Cre cKO (fig. S4B–C). Morphological examination showed that the loss of club hair was correlated with upward movement of the club hair, likely caused by reduced cell adhesion but not by abnormal apoptosis or proliferation of the SBL (fig. S4D–F).
The widespread loss of club hair was further confirmed by flow cytometry analysis, by which HFSCs were detected as H2BGFPhi/CD34hi/α6hi and H2BGFPhi/CD34hi/α6lo populations in WT skin(5). The H2BGFPhi/CD34hi/α6lo population marks a cell population sandwiched between the club hair and the new hair follicle, characteristic of the two-bulge formation in WT skin(5) (fig. S5A). Consistent with the morphological results, we observed a progressive loss of the H2BGFPhi/CD34hi/α6lo population in the K14-Cre and Foxn1-Cre cKO between P30 and P47 (fig. S5B–C). CD34 levels in the KO HFSCs were also reduced (fig. S5D). These data provide evidence for the requirement of Foxc1 in restricting HFSCs from premature activation and maintaining the club hair. The Foxn1-Cre cKO results suggest Foxc1 is required by the SBL to maintain the club hair. The K15-CrePR cKO results reveal an intrinsic requirement of Foxc1 by HFSCs and suggest that temporal induction of Foxc1 in the activated HFSCs during anagen is required to reinforce quiescence.
To determine the effect of loss of Foxc1 on HFSC quiescence, we performed RNA-Seq at P47 when both WT and K14-Cre cKO HFSCs were in telogen. Genes associated with quiescence of HFSCs, including Bmp6(11) and Fgf18(12, 13), and HFSC markers(4, 5, 14) including CD34 were among the significantly downregulated genes whereas genes associated with HFSC activation were upregulated in the cKO (Fig. 3A). Signature genes characteristic of quiescent SCs(3) were dysregulated (Fig. 3A). Global analysis revealed that genes involved in cell division were significantly upregulated (fig. S6A). We then confirmed by qPCR the downregulation of Bmp6, CD34, and Fgf18 and the upregulation of cell cycle genes in the HFSCs purified from each model. Consistent with the cell-intrinsic requirement of Foxc1 in the HFSCs during anagen, changes of gene expression were only observed in the K14-Cre and K15-CrePR models, in which Foxc1 was constitutively deleted or specifically deleted in the HFSCs before anagen respectively, but not in the Foxn1-Cre and K15-CrePR models, in which Foxc1 was deleted in the SBL but not in the HFSCs or specifically deleted in the HFSC after anagen respectively (Fig. 3B, fig. S7).
Next we performed Gene Set Enrichment Analysis (GSEA) using published HFSC and progenitor datasets(15). Quiescent Foxc1 KO HFSCs (P47) were more similar to HG progenitors that are poised for activation than to quiescent HFSCs (Fig. 3C, fig. S8). We also observed a strong similarity between Foxc1 and Lhx2 cKO HFSCs in their molecular signature (fig. S8). We then performed principal component analysis (PCA) using datasets from the quiescent or activated HFSCs(8, 12, 16), the HGs(12), the transit-amplifying cells (TACs)(8) and our RNA-Seq data. We found that activated HFSCs (P28) and dividing HFSCs destined for differentiation (P20)(16) were intermediate populations between quiescent HFSCs and HG progenitors. The P47 Foxc1 KO HFSCs were grouped most closely with activated HFSCs and clearly distinct from quiescent HFSCs (Fig. 3D). These data provide a global view for the sensitized cellular state of the Foxc1 KO HFSCs prior to the premature SC activation.
To determine the mechanism of Foxc1’s action, we analyzed differentially expressed genes in Foxc1 WT and KO HFSCs between P29 and P31, when the HFSCs are activated and when Foxc1 is highly expressed. Genes associated with HFSC quiescence, HFSC markers, and adhesion were notably downregulated and cell cycle regulators were strongly upregulated in the cKO, consistent with the observed phenotypes (Fig. 4A, fig. S6B). These data suggest that the transient expression of Foxc1 maintains SC adhesion and promotes the transition back to quiescence when the HFSCs undergo self-renewal.
Next we mapped open chromatin regions and TF occupancy in the WT and KO HFSCs using ATAC-Seq(17). We analyzed published ChIP-Seq data for Sox9(18), Tcf3/4(19) and Lhx2(20) in HFSCs and observed strong overlaps between ChIP-Seq and ATAC-Seq peaks, validating the detection of TF occupancy by ATAC-seq (fig. S9A–C). To determine Foxc1 recognition motifs, we analyzed a Foxc1 ChIP-Seq dataset(21). De novo motif discovery retrieved Foxc1 binding sites that were best matched by previously determined Foxa2 and Foxa1 recognition motifs (fig. S9D). Notably, Foxa2 and Foxc1 were validated to bind to the same enhancer sequences(22), consistent with our findings. Both Foxa1 and Foxa2 loci are epigenetically silenced in HFSCs (fig. S10), suggesting Foxc1 is responsible for these binding sites. We then intersected our ATAC-seq peaks harboring the Foxc1 recognition motifs with differentially expressed genes (p<0.01) in the Foxc1 KO HFSCs. We identified 104 genes likely to be targeted by Foxc1 (table S1). Among these putative targets, 85 (81.7%) were downregulated in the Foxc1 KO HFSCs (fig. S9E). Several genes involved in regulating HFSC quiescence were found to contain Foxc1 binding sites in their promoter or enhancer regions, including Bmp2(23), Foxp1(24), Nfatc1(25, 26), Prlr(26, 27).
We further dissected pathways that are downstream from Foxc1. Since ATAC-seq provided a comprehensive survey for all TF binding sites in the genome, we analyzed the top TF hits in our ATAC-seq. Overall in the HFSCs, motifs representing AP-1/c-Jun, p63 and CTCF were the most significantly enriched sequences that were detected by ATAC-seq, consistent with high expression levels and the widespread roles of these TFs in the skin (Fig. 4B). However, when we specifically searched the subset of ATAC-seq peaks that cover the differentially expressed (DE) genes identified in the Foxc1 KO HFSCs against ATAC peaks of non-DE genes, motifs representing Foxc1, Nfatc1, and Smad, reflecting the BMP signaling pathway, were significantly enriched (Fig. 4B). Furthermore, GSEA comparison showed that direct targets of Nfatc1(28) and pSMAD1/5(29) were significantly enriched and largely downregulated in the Foxc1 KO HFSCs, thus positively linking the Foxc1 KO HFSCs to the compromised Bmp signaling pathway and loss of Nfatc1 in the HFSCs(29,30) (Fig. 4C). Sixty-six of these genes, including Bmp2, Bmp6, Foxp1, Inpp4b, Nfatc1 and Prlr, were likely co-regulated by Foxc1, Nfatc1 and Smad (Fig. 4D, tables S2–3). Such a combinatorial action of these TFs is illustrated by the Nfatc1 locus (Fig. 4E). The direct regulation of Nfatc1, Bmp6 and Hspb8 by Foxc1 was confirmed by ChIP-PCR and qPCR (Fig. 4F–G, fig. S11). Because Hspb8 was confirmed as a Smad target(29), it is an example co-regulated by Foxc1 and Smad. Overall, 343 out of 421 differentially expressed genes are likely controlled by Foxc1 directly (104) or by Nfatc1 (170) and Smad (328) indirectly, indicating a collaborative gene regulatory network between Foxc1 and Nfatc1 as well as Bmp signaling, two critical regulatory networks governing the quiescence of HFSCs(11, 12, 23, 25, 30, 31).
In conclusion, we have uncovered a dynamic and cell-intrinsic mechanism mediated by Foxc1 that is induced to promote quiescent SC identity in response to SC activation. Our findings also suggest that quiescent SCs actively sense the change of their cellular states and utilize transient gene expression to reinforce their identity. Investigation of such adaptive mechanisms should provide new insights into SC maintenance during tissue homeostasis and injury repair.
Supplementary Material
Acknowledgments
We thank members of the Yi laboratory for discussions, P. Muhlrad and T. Cech for critical reading of the manuscript, Y. Han for FACS, K. Diener and B. Gao for Illumina sequencing, J. Tyler for imaging. We thank E. Fuchs (Rockefeller University) for K14-Cre and K14-H2BGFP mice, H. Chang (Stanford University) for help on ATAC-seq, N. Manley (University of Georgia) for Foxn1-Cre mice, D. Roop and G. Bilousova (University of Colorado, Denver) for Krt6 antibody. This project was partly supported by NIH grant AR066703 and a start-up fund from the University of Colorado Boulder to R.Y. L.W. was supported by an NIH training grant T32GM008759. R.Y. and R.D.D. were co-advisors for L.W. All sequencing data are deposited to GEO with the accession number GSE67404 and GSE68288.]
Footnotes
The authors declare no conflicts of interest.
References and Notes
- 1.Orford KW, Scadden DT. Nat Rev Genet. 2008;9:115–128. doi: 10.1038/nrg2269. [DOI] [PubMed] [Google Scholar]
- 2.He S, Nakada D, Morrison SJ. Annu Rev Cell Dev Biol. 2009;25:377–406. doi: 10.1146/annurev.cellbio.042308.113248. [DOI] [PubMed] [Google Scholar]
- 3.Cheung TH, Rando TA. Nat Rev Mol Cell Biol. 2013;14:329–340. doi: 10.1038/nrm3591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Tumbar T, et al. Science. 2004;303:359–63. doi: 10.1126/science.1092436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. Cell. 2004;118:635–48. doi: 10.1016/j.cell.2004.08.012. [DOI] [PubMed] [Google Scholar]
- 6.Cotsarelis G, Sun TT, Lavker RM. Cell. 1990;61:1329–37. doi: 10.1016/0092-8674(90)90696-c. [DOI] [PubMed] [Google Scholar]
- 7.Blanpain C, Fuchs E. Nat Rev Mol Cell Biol. 2009;10:207–17. doi: 10.1038/nrm2636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lien WH, et al. Cell Stem Cell. 2011;9:219–232. doi: 10.1016/j.stem.2011.07.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kume T, et al. Cell. 1998;93:985–996. doi: 10.1016/s0092-8674(00)81204-0. [DOI] [PubMed] [Google Scholar]
- 10.Hsu YC, Pasolli HA, Fuchs E. Cell. 2011;144:92–105. doi: 10.1016/j.cell.2010.11.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Oshimori N, Fuchs E. Cell Stem Cell. 2012;10:63–75. doi: 10.1016/j.stem.2011.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Greco V, et al. Cell Stem Cell. 2009;4:155–69. doi: 10.1016/j.stem.2008.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kimura-Ueki M, et al. J Invest Dermatol. 2012;132:1338–1345. doi: 10.1038/jid.2011.490. [DOI] [PubMed] [Google Scholar]
- 14.Morris RJ, et al. Nat Biotechnol. 2004;22:411–7. doi: 10.1038/nbt950. [DOI] [PubMed] [Google Scholar]
- 15.Subramanian A, et al. Proc Natl Acad Sci. 2005;102:15545–15550. doi: 10.1073/pnas.0506580102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Zhang YV, Cheong J, Ciapurin N, McDermitt DJ, Tumbar T. Cell Stem Cell. 2009;5:267–278. doi: 10.1016/j.stem.2009.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Nat Methods. 2013;10:1213–1218. doi: 10.1038/nmeth.2688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kadaja M, et al. Genes Dev. 2014;28:328–341. doi: 10.1101/gad.233247.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lien WH, et al. Nat Cell Biol. 2014;16:179–190. doi: 10.1038/ncb2903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Folgueras AR, et al. Cell Stem Cell. 2013;13:314–27. doi: 10.1016/j.stem.2013.06.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Amin S, et al. Dev Cell. 2015;32:265–277. doi: 10.1016/j.devcel.2014.12.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Yamagishi H, et al. Genes Dev. 2003;17:269–281. doi: 10.1101/gad.1048903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Plikus MV, et al. Nature. 2008;451:340–344. doi: 10.1038/nature06457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Leishman E, et al. Dev Camb Engl. 2013;140:3809–3818. doi: 10.1242/dev.097477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Horsley V, Aliprantis AO, Polak L, Glimcher LH, Fuchs E. Cell. 2008;132:299–310. doi: 10.1016/j.cell.2007.11.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Goldstein J, et al. Genes Dev. 2014;28:983–994. doi: 10.1101/gad.236554.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Craven AJ, et al. Endocrinology. 2001;142:2533–2539. doi: 10.1210/endo.142.6.8179. [DOI] [PubMed] [Google Scholar]
- 28.Keyes BE, et al. Proc Natl Acad Sci U S A. 2013;110:E4950–4959. doi: 10.1073/pnas.1320301110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Genander M, et al. Cell Stem Cell. 2014;15:619–633. doi: 10.1016/j.stem.2014.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Kobielak K, Stokes N, de la Cruz J, Polak L, Fuchs E. Proc Natl Acad Sci U A. 2007;104:10063–8. doi: 10.1073/pnas.0703004104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Botchkarev VA, et al. Nat Cell Biol. 1999;1:158–164. doi: 10.1038/11078. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.